Quick Answer
Altimmune, Inc. reported Total Assets of $279.93 million for fiscal year 2025.
Altimmune, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $279.93M | +100.9% |
| 2024 | $139.31M | -33.9% |
| 2023 | $210.64M | +1.8% |
| 2022 | $206.93M | -5.5% |
| 2021 | $218.87M | -10.7% |
| 2020 | $245.12M | +353.4% |
| 2019 | $54.06M | -1.3% |
| 2018 | $54.75M | -13.1% |
| 2017 | $63.03M | +64.1% |
| 2016 | $38.40M | +93.3% |
| 2015 | $19.86M | -9.6% |
| 2014 | $21.98M | +28.2% |
| 2013 | $17.14M | -24.6% |
| 2012 | $22.74M | -0.3% |
| 2011 | $22.80M | -16.2% |
| 2010 | $27.20M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $218.45M | +47.7% | +14.8% |
| June 30, 2025 | $190.35M | +9.8% | +21.0% |
| March 31, 2025 | $157.26M | -16.5% | +12.9% |
| December 31, 2024 | $139.31M | -33.9% | -5.8% |
| September 30, 2024 | $147.86M | -11.2% | -14.7% |
| June 30, 2024 | $173.35M | -5.4% | -8.0% |
| March 31, 2024 | $188.36M | +0.7% | -10.6% |
| December 31, 2023 | $210.64M | +1.8% | +26.5% |
- Altimmune, Inc. showed an increase of +100.9% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Altimmune, Inc.’s total assets has grown by 929.2% (from $27.20 million to $279.93 million).
- The most recent figure is from Altimmune, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: